10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript November 6, 2025
10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.07.
Operator: Thank you for standing by. Welcome to the 10X Genomics’ Third Quarter 2025 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Cassie Corneau, Senior Director, Investor Relations and Strategic Finance. You may begin.
Cassie Corneau: Thank you. And good...
